SCHEMBL4837033

SCHEMBL4837033

O=C1C2CC3C(=O)N(OS(=O)(=O)c4ccccc4)C(=O)C3CC2C(=O)N1OS(=O)(=O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARL Q9H300 3/20 0.64
ALDH1A1 P00352 8/20 0.57
KMT2A Q03164 4/20 0.57
MAPT P10636 4/20 0.57
KDM4E B2RXH2 3/20 0.57
HPGD P15428 2/20 0.57
MEN1 O00255 3/20 0.49
HTT P42858 1/20 0.49
VDR P11473 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
F2 P00734 1/20 0.41
POLB P06746 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
CYP2C9 P11712 1/20 0.37
MMP2 P08253 1/20 0.37
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4831931 0.85 KMT2A (0.55) PARLALDH1A1KMT2AMAPTKDM4E
SCHEMBL4829803 0.84 PARL (0.65) PARLALDH1A1KMT2AMAPTKDM4E
SCHEMBL4837175 0.83 ALDH1A1 (0.50) PARLALDH1A1KMT2AMAPTKDM4E
SCHEMBL4837258 0.83 VDR (0.58) PARLALDH1A1KMT2AMAPTKDM4E
SCHEMBL4832240 0.83 KDM4E (0.50) PARLALDH1A1KMT2AMAPTKDM4E
SCHEMBL4830039 0.83 PARL (0.44) PARLALDH1A1KMT2AMAPTKDM4E
SCHEMBL4826503 0.81 GAA (0.49) PARLALDH1A1MAPTHTTVDR
SCHEMBL22251615 0.81 ALDH1A1 (0.64) PARLALDH1A1KMT2AMAPTKDM4E
SCHEMBL13583550 0.81 PARL (0.57) PARLALDH1A1KMT2AMAPTKDM4E
SCHEMBL14569437 0.81 PARL (0.61) PARLALDH1A1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 PARL 1086/4885ALDH1A1 633/4885KMT2A 1016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.